help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ethier, J.-F.
Right arrow Articles by Silversides, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ethier, J.-F.
Right arrow Articles by Silversides, D. W.
Endocrinology Vol. 138, No. 6 2425-2434
Copyright © 1997 by The Endocrine Society


ARTICLES

Bovine Activin Receptor Type IIB Messenger Ribonucleic Acid Displays Alternative Splicing Involving a Sequence Homologous to Src-Homology 3 domain Binding Sites1

Jean-François Ethier, Jacques G. Lussier and David W. Silversides

Centre de Recherche en Reproduction Animale (CRRA), Department of Veterinary Biomedicine, Faculty of Veterinary Medicine, University of Montreal, St-Hyacinthe, Québec, Canada

Address all correspondence and requests for reprints to: David W. Silversides, Centre de Recherche en Reproduction Animale (CRRA), Department of Veterinary Biomedicine, Faculty of Veterinary Medicine, University of Montreal, P.O. Box 5000, St-Hyacinthe, Québec, Canada, J2S 7C6. E-mail: silverdw{at}ere.umontreal.ca

Activins are implicated in a variety of biological effects, particularly in reproductive processes such as embryonic development and folliculogenesis. Breakthroughs in the elucidation of the activin signal transduction mechanism were achieved with the characterization of the activin receptors, and the recent identification of cytoplasmic factors apparently involved in the signaling process. The present studies were undertaken to further analyze the activin signaling pathway. The complementary DNA coding for the bovine activin receptor type IIB (bActRIIB) was amplified by RT-PCR from corpus luteum and pituitary RNA, and cloned to characterize its role in activin signal transduction. Two complementary DNA isoforms (bAct-RIIB2 and bActRIIB5) were detected, coding for 512 amino acids and 498 amino acids, respectively. The shortest isoform lacked a sequence encoding a 14-amino acid stretch very rich in proline residues, located between the transmembrane region and the intracellular kinase domain. Intron sequencing and ribonuclease protection assay demonstrated that alternative splicing is responsible for the generation of these bActRIIB isoforms. This alternative splicing event is unique in that it has not been observed in other species, including the mouse, in which extensive alternative splicing of the ActRIIB messenger RNA is described. Comparison of this alternative sequence with other known proline-rich sequences showed that it has characteristics of a Src-homology 3 domain (SH3) binding site. Coprecipitation experiments have identified two proteins of 69 kDa and 71 kDa from an uterine endometrial cell line, specifically interacting with the short bActRIIB alternative proline-rich sequence. These results suggest that bActRIIB could have a protein-protein interaction, through its putative SH3 binding site, with at least two intracellular SH3-containing proteins.




This article has been cited by other articles:


Home page
J EndocrinolHome page
Z H Liu, K Tsuchida, T Matsuzaki, Y L Bao, A Kurisaki, and H Sugino
Characterization of isoforms of activin receptor-interacting protein 2 that augment activin signaling.
J. Endocrinol., May 1, 2006; 189(2): 409 - 421.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. Dupont, J. McNeilly, A. Vaiman, S. Canepa, Y. Combarnous, and C. Taragnat
Activin Signaling Pathways in Ovine Pituitary and L{beta}T2 Gonadotrope Cells
Biol Reprod, May 1, 2003; 68(5): 1877 - 1887.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Matsuzaki, S. Hanai, H. Kishi, Z. Liu, Y. Bao, A. Kikuchi, K. Tsuchida, and H. Sugino
Regulation of Endocytosis of Activin Type II Receptors by a Novel PDZ Protein through Ral/Ral-binding Protein 1-dependent Pathway
J. Biol. Chem., May 17, 2002; 277(21): 19008 - 19018.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. E. Drummond, M. T. Le, J.-F. Ethier, M. Dyson, and J. K. Findlay
Expression and Localization of Activin Receptors, Smads, and {beta}glycan to the Postnatal Rat Ovary
Endocrinology, April 1, 2002; 143(4): 1423 - 1433.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Shoji, K. Tsuchida, H. Kishi, N. Yamakawa, T. Matsuzaki, Z. Liu, T. Nakamura, and H. Sugino
Identification and Characterization of a PDZ Protein That Interacts with Activin Type II Receptors
J. Biol. Chem., February 25, 2000; 275(8): 5485 - 5492.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society